Radcliffe Capital Management, L.P. - SAB BIOTHERAPEUTICS INC ownership

Back to all holdings Add to watchlist

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T111. A total of 16 filers reported holding SAB BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2022$27,000
-66.7%
38,927
-30.1%
0.00%
-50.0%
Q2 2022$81,000
-85.6%
55,6920.0%0.00%
-84.6%
Q1 2022$562,000
-11.1%
55,692
-31.2%
0.01%
-23.5%
Q4 2021$632,000–80,897–0.02%–
 Download
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Yakira Capital Management, Inc. 108,485$8,1360.00%
Shaolin Capital Management LLC 465,717$330.00%
WOLVERINE ASSET MANAGEMENT LLC 12,765$8930.00%
MORGAN STANLEY 148,939$10,4260.00%
Walleye Trading LLC 15,505$1,0850.00%
Walleye Capital LLC 23,258$1,6280.00%
Tower Research Capital LLC (TRC) 48$40.00%
LMR Partners LLP 539,588$37,7710.00%
NewEdge Advisors, LLC 1,072$750.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders